Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells

Genes Chromosomes and Cancer

Volumn 46, Issue 12, 2007, Pages 1069-1079

  Buys, Timon P H ^a   Chari, Raj ^a   Lee, Eric H L ^a   Zhang, May ^a   MacAulay, Calum ^a   Lam, Stephen ^a   Lam, Wan L ^a   Ling, Victor ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLYCOPROTEIN P;

ABCBI GENE; ABCC6 GENE; ABCCI GENE; AMPLICON; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CANCER INVASION; CELL PROLIFERATION; CHROMOSOME 16P; CHROMOSOME 7Q; COMPARATIVE ANATOMY; COMPARATIVE GENOMIC HYBRIDIZATION; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE ACTIVATION; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRAIT; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL;

CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EVOLUTION, MOLECULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PHENOTYPE;

EID: 35349005781     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20492     Document Type: Article

References (40)

1. Adamia S, Maxwell CA, Pilarski LM. 2005. Hyaluronan and hyaluronan synthases: Potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5:3-14.
2. Alt FW, Kellems RE, Bertino JR, Schimke RT. 1978. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem 253:1357-1370.
3. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL. 2005. Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65:7561-7567.
4. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. 2002. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62:6172-6177.
5. Borst P, Elferink RO. 2002. Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592.
6. Bradley G, Naik M, Ling V. 1989. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines. Cancer Res 49:2790-2796.
7. Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A, Perris R. 2004. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18:779-781.
8. Chari R, Lockwood WW, Coe BP, Chu A, Macey D, Thomson A, Davies JJ, Macaulay C, Lam WL. 2006. SIGMA: A System for integrative genomic microarray analysis of cancer genomes. BMC Genomics 7:324.
9. Chi B, DeLeeuw RJ, Coe BP, MacAulay C, Lam WL. 2004. SeeGH - A software tool for visualization of whole genome array comparative genomic hybridization data. BMC Bioinformatics 5:13.
10. Coe BP, Lee EH, Chi B, Girard L, Minna JD, Gazdar AF, Lam S, MacAulay C, Lam WL. 2006. Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines. Genes Chromosomes Cancer 45:11-19.
11. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
12. Duan Z, Brakora KA, Seiden MV. 2004. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells. Mol Cancer Ther 3:833-838.
13. Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV. 2006. GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemother Pharmacol 57:25-33.
14. Frank NY, Pendse SS, Lapchak PH, Margaryan A, Shlain D, Doeing C, Sayegh MH, Frank MH. 2003. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 278:47156-47165.
15. Garnis C, Baldwin C, Zhang L, Rosin MP, Lam WL. 2003. Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas. Cancer Res 63:8582-8585.
16. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP, Lam WL. 2004. Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer. Genes Chromosomes Cancer 39:93-98.
17. Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM, Dalton WS. 2006. Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res 66:2338-2345.
18. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, Lam WL. 2004. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36:299-303.
19. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B. 2004. Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics 20:3636-3637.
20. Juliano RL, Ling V. 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152-162.
21. Khojasteh M, Lam WL, Ward RK, MacAulay C. 2005. A stepwise framework for the normalization of array CGH data. BMC Bioinformatics 6:274.
22. Kool M, van der Linden M, de Haas M, Baas F, Borst P. 1999. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59:175-182.
23. Kruh GD, Belinsky MG. 2003. The MRP family of drug efflux pumps. Oncogene 22:7537-7552.
24. Leonard GD, Fojo T, Bates SE. 2003. The role of ABC transporters in clinical practice. Oncologist 8:411-424.
25. Miletti-Gonzalez KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, Apolito K, Shih WJ, Hait WN, Rodriguez-Rodriguez L. 2005. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res 65:6660-6667.
26. Misra S, Ghatak S, Toole BP. 2005. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem 280: 20310-20315.
27. Poon RT, Chung KK, Cheung ST, Lau CP, Tong SW, Leung KL, Yu WC, Tuszynski GP, Fan ST. 2004. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res 10:4150-4157.
28. Ricciardelli C, Rodgers RJ. 2006. Extracellular matrix of ovarian tumors. Semin Reprod Med 24:270-282.
29. Schmidt WM, Kalipciyan M, Dornstauder E, Rizovski B, Sedivy R, Steger GG, Muller MW, Mader RM. 2003. Gene expression profiling of colon cancer reveals a broad molecular repertoire in 5-fluorouracil resistance. Int J Clin Pharmacol Ther 41:624-625.
30. Schmidt WM, Kalipciyan M, Dornstauder E, Rizovski B, Steger GG, Sedivy R, Mueller MW, Mader RM. 2004. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int J Cancer 112:200-212.
31. Shain KH, Dalton WS. 2001. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): New targets for the prevention of acquired MDR. Mol Cancer Ther 1:69-78.
32. Stefkova J, Poledne R, Hubacek JA. 2004. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res 53:235-243.
33. Sturn A, Quackenbush J, Trajanoski Z. 2002. Genesis: Cluster analysis of microarray data. Bioinformatics 18:207-208.
34. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. 2006. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219-234.
35. Toole BP. 2004. Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer 4:528-539.
36. Tringler B, Grimm C, Sliutz G, Leodolter S, Speiser P, Reinthaller A, Hefler LA. 2005. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma. Gynecol Oncol 99:80-83.
37. Uitto J. 2005. The gene family of ABC transporters - Novel mutations, new phenotypes. Trends Mol Med 11:341-343.
38. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB. 2005. The interaction of versican with its binding partners. Cell Res 15:483-494.
39. Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, Tsuruo T, Inazawa J. 2004. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 64:1403-1410.
40. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS, Yang BB. 2004. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18:754-756.